Neha Suri, M.S. is a Senior Director with Fuld’s Health and Life Sciences Practice. Ms. Suri has 6 years of experience providing consulting and analysis services to life science companies. Prior to joining Fuld, Ms. Suri was a Project Manager at Global Prior Art, Inc., an intellectual property research and consulting firm. In that position, she worked closely with biotechnology and pharmaceutical companies and law firms to conduct market assessment projects, support patent litigation and prosecution and create intellectual property landscapes. She has acquired expertise working on a variety of areas, including pharmaceuticals, diagnostics, immunology, neurology, diabetes, medical devices and many more biotechnology-related areas. Prior to that, Ms. Suri also gained lab research experience at Amgen. Her research experience at Amgen focused on understanding the multiple sclerosis pathway and developing an assay for identify novel therapeutic candidates for MS.
Ms. Suri holds a M.S. in Biotechnology from University of Pennsylvania and B.S. in Biotechnology from Jaypee Institute, India. Her Graduate work focused on developing a high-throughput screening assay to identify drug candidates for Duchenne Muscular Dystrophy (DMD).